Loading clinical trials...

Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients | Clinical Trials | Clareo Health

COMPLETEDPhase 1NCT01291069

Effect of Tadalafil on Exercise Capacity in Pediatric Fontan Patients

This pilot study is aimed at assessing the short-term effects of Tadalafil on the hemodynamic response to exercise and exercise capacity in patients with Fontan circulation. Data regarding effect size...

Lead sponsor: University of Utah•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Adult Congenital Heart Disease International EValuation of the Effectiveness of SGLT2i Registry

NCT06932081 · Adult Congenital Heart Disease, Congenital Heart Disease, and more

COMPLETEDNA

Cognitive Intervention to Improve Working Memory

NCT03687008 · Single Ventricle Heart Disease

COMPLETEDPhase 4

Effect of Carvedilol on Exercise Performance in Fontan Patients

NCT02946892 · Single Ventricle, Fontan

COMPLETED

Diffuse Myocardial Fibrosis in Fontan Patients

NCT01929174 · Congenital Heart Disease, Single Ventricle, and more

TERMINATEDPhase 4

The Effects of Eplerenone on Markers of Myocardial Fibrosis in Adult Congenital Heart Disease

NCT01971593 · Tetralogy of Fallot, Transposition of the Great Vessels With an Arterial Switch, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 17, 2017Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1

Enrollment20

Start dateSep 2011

Last updatedApr 17, 2017

Condition

Single Ventricle

Locations shown

Primary Childrens Medical Center

Salt Lake City, Utah

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 17, 2017Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions